Dear <<First Name>>,
3D InSight™ Human Liver Microtissues continue to help make inroads in novel toxicology applications. Check out the latest news below in our October Tox Update.
|
|
|
Nanotoxicology Explored in 3D Liver Microtissues
Findings in a paper co-authored by InSphero and published yesterday in the journal Particle and Fibre Toxicology suggest InSphero 3D InSight™ Human Liver Microtissues are an excellent candidate for replacement of traditional in vitro single cell hepatic models when exploring nanotoxicology. Read more and get the open access article. |
InSphero Wins ACES Award for Top European Academic Enterprise
On the heels of being named the #1 Swiss Startup in September, we were honored on October 7th with the ACES award as the Top European Academic Enterprise in Life Sciences. Read more here. |
|
Webinar: Acetaminophen Toxicity Assessment by Q Exactive HF MS
Dr. Lukas Reiter, Head of Research & Development for BiognoSYS AG will present data profiling thousands of proteins in 3D InSight™ Human Liver Microtissues following Acetaminophen treatment in this October 30th webinar sponsored by Thermo Scientific. Learn more and register.
|
|
|
|
|
Meet us here - Fairs & Events
ISSX/JSSX Joint Meeting, San Francisco, CA, Oct 18-23
InSphero User Group Meeting, San Francisco, CA, Oct 24
EACR Goodbye Flat Biology, Berlin, DE, Nov 2-5
InSphero User Group Meeting, Boston, MA, Nov 20
|
|
|
|
